Philippines approves GMO golden rice for commercial production
By Staff,
GMWatch
| 07. 23. 2021
No independent health risk assessment was done; Farmer-scientist group MASIPAG condemns decision
The Philippines has approved GMO golden rice for commercial production. This is in spite of the fact that no independent data on the safety of this GMO for health and the environment have been published; that beta-carotene, which the rice is engineered to contain, is one of the commonest molecules in nature and numerous native plants contain high levels; and that the US FDA says that GMO golden rice doesn't contain enough beta-carotene to justify a health claim.
As Glenn Davis Stone and Dominic Glover point out, it is still unknown if the beta-carotene in GMO golden rice can even be converted to Vitamin A in the bodies of badly undernourished children. In addition, research shows that what beta-carotene there is in the rice degrades rapidly in storage. Cooking further degrades the beta-carotene.
Meanwhile, as the development of golden rice creeps along, the Philippines has managed to slash the incidence of Vitamin A deficiency by non-GMO methods.
The author of the France24 article below is clearly ignorant of these crucial facts.
1. Philippines approves GMO 'golden rice'...
Related Articles
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Tory Shepherd, The Guardian | 06.13.2025
IVF is “big business” and experts are concerned about conflicts of interest between profit-making and helping families have children.
Monash IVF’s second embryo bungle has sparked renewed scrutiny on the IVF industry as a whole amid calls for national regulation...
By Hilary Bowman-Smart and Craig Stanbury, The Conversation | 06.12.2025